You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hlx10

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Solid Tumor Trial (HLX26, HLX10)

Recruiting
  • Adult Solid Tumor
  • Xuzhou, Jiangsu, China
    Xuzhou Central Hospital
Oct 17, 2022

Metastatic Colorectal Cancer Trial in China (HLX10/Placebo, HLX04/Avastin)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
  • +3 more
Dec 19, 2022

Colorectal Cancer Metastatic Trial (HLX26, HLX10)

Not yet recruiting
  • Colorectal Cancer Metastatic
  • (no location specified)
Oct 14, 2022

CRC Trial (HLX07, HLX10, mFOLFOX6)

Not yet recruiting
  • CRC
  • (no location specified)
May 1, 2022

Solid Tumor, Adult Trial (HLX35, HLX10)

Not yet recruiting
  • Solid Tumor, Adult
  • (no location specified)
Jun 29, 2022

Limited Stage Small Cell Lung Cancer Trial (HLX10, hypofractionated radiotherapy, Prophylactic Cranial Irradiation (PCI))

Not yet recruiting
  • Limited Stage Small Cell Lung Cancer
  • HLX10
  • +2 more
  • (no location specified)
Jun 29, 2022

Cervical Cancer Trial in Beijing (HLX10, Paclitaxel, Cisplatin)

Withdrawn
  • Cervical Cancer
  • HLX10
  • +4 more
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 1, 2022

Extensive Stage Small Cell Lung Cancer Trial in Shanghai (HLX10, carboplatin and etoposide, )

Active, not recruiting
  • Extensive Stage Small Cell Lung Cancer
  • HLX10
  • +2 more
  • Shanghai, China
  • +5 more
Sep 28, 2022

Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in Guanzhou (HLX07, HLX10, )

Not yet recruiting
  • Nasopharyngeal Carcinoma by AJCC V8 Stage
  • Guanzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 23, 2022

Small-cell Lung Cancer Trial in Changchun (HLX07, HLX10, carboplatin and etoposide)

Not yet recruiting
  • Small-cell Lung Cancer
  • Changchun, Jilin, China
    Jilin Cancer Hospital
May 3, 2022

Advanced Hepatocellular Carcinoma Trial (HLX07, HLX10, HLX04)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
May 1, 2022

MSI-H Solid Malignant Tumor Trial in China (HLX10)

Recruiting
  • MSI-H Solid Malignant Tumor
  • HLX10
  • Hefei, Anhui, China
  • +32 more
Oct 26, 2022

Limited-Stage Small Cell Lung Cancer Trial in Jinan (HLX10, carboplatin/cisplatin-etoposide, Thoracic radiotherapy)

Recruiting
  • Limited-Stage Small Cell Lung Cancer
  • HLX10
  • +4 more
  • Anaheim, California
  • +83 more
Jan 12, 2023

Squamous Non Small Cell Lung Cancer Trial in Worldwide (HLX10, carboplatin and nab paclitaxel, Placebo)

Active, not recruiting
  • Squamous Non Small Cell Lung Cancer
  • HLX10
  • +2 more
  • Roanoke, Virginia
  • +91 more
Apr 25, 2022

Solid Tumor Trial in Taipei City (HLX10)

Unknown status
  • Solid Tumor
  • HLX10
  • Taipei City, Taiwan
    Taipei Municipal Wanfang Hospital
May 28, 2020

Triple Negative Breast Cancer Trial (HLX10, nab-paclitaxel, carboplatin, doxorubicin or epirubicin and cyclophosphamide,

Not yet recruiting
  • Triple Negative Breast Cancer
  • HLX10
  • +2 more
  • (no location specified)
Mar 10, 2020

Solid Tumor Trial in Shanghai (HLX04, HLX10)

Unknown status
  • Solid Tumor
  • Shanghai, China
    Shanghai East Hospital
May 22, 2019